Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
ALGT heads into its October 30 earnings with short interest at a 30-day high, analyst targets falling across the board, and the stock trading at less than half the mean price target, a gap that tells its own story about how much work the company has to do to rebuild credibility.
Short interest has climbed sharply over the past month, the clearest sign that bearish positioning is intensifying. At 13.8% of free float, the short book is up 28% over the past 30 days and has been drifting higher through September, rising from around 1.9 million shares borrowed in late August to 2.44 million today. Despite that build, borrow conditions remain easy. Availability is ample, with roughly 9.6 shares available for every one already lent out, well above the 52-week floor of around 3x. The cost to borrow is only 0.46%, barely above what it was a month ago. That combination, a growing short position and an unconstrained lending pool, tells you this is conviction shorting rather than a crowded trade facing squeeze pressure.
Options positioning cuts against the bearish grain. Call demand is running ahead of puts, with the put/call ratio at 0.40, below its 20-day average of 0.45 and well beneath where it sat in mid-September when the PCR was above 0.54. The 52-week high for the PCR was 1.03, so the current reading reflects a notably call-heavy posture relative to this stock's own history. That divergence, shorts building while options traders lean bullish, is the sharpest tension in the setup right now.
The Street has been cutting targets relentlessly but, with a couple of notable exceptions, has not abandoned the stock. Susquehanna just this week slashed its target from $110 to $85 while keeping a Neutral rating, a move that dragged the analyst mean target to $120. That mean still implies around 55% upside from the $77.54 close, which ordinarily would sound like a buy signal but masks the directionality of recent revisions. Every firm that has touched the stock since mid-July has lowered its target, including Barclays cutting from $145 to $115 on its Overweight in September, and UBS simultaneously upgrading to Buy while trimming to $107. The EV/EBITDA multiple is running near 3.8x with the price-to-book at 0.86x, both compressed even by airline standards. The 90-day EPS momentum factor scores in the 94th percentile, suggesting forward estimates have been rising sharply despite the target cuts, a somewhat unusual pairing. The analyst recommendation differential factor ranks in the 93rd percentile, meaning the net bullishness of the analyst community is high relative to the broader universe, yet the targets keep coming down.
The activist register is worth flagging. Maurice Gallagher, Allegiant's founder and former CEO, holds 11.1% of the company under a Schedule 13D filing, down from 12.8% at his previous disclosure in March 2026. A 13D carries activist intent, and Gallagher's continued presence at that level, even as he trims, is a structural feature of this stock that limits certain outcomes for any short thesis. BlackRock separately holds 13% on a passive 13G basis and has been adding meaningfully. As always with 13D/G positions: stakes are as last disclosed and holders who fall below 5% are not required to file again, so the register reflects a snapshot rather than a live reading. The insider activity over the recent period is all coded as tax-withholding transactions (type F), which are compensation mechanics rather than discretionary sales. The CEO's 4,832-share withholding on October 1 at $75.46 and the cluster of officer transactions on September 23 carry no sentiment signal.
Wikipedia attention for Allegiant is running more than 2.7 standard deviations above its own 90-day average, an unusually elevated retail attention reading for a stock that doesn't typically generate much buzz. Whether that reflects growing retail interest ahead of earnings or noise from press coverage of the analyst cuts is hard to disentangle from the data alone.
Peer performance this week adds another wrinkle. ALGT gained 0.7% on the week while AAL fell 4.5% and JBLU dropped 6.3%. The budget and leisure carriers generally had a rough week, making Allegiant's relative stability notable. UAL and DAL both slipped 0.7% to 1.4%, and only ULCC and CPA outperformed. The October 30 print will be the first chance to test whether the recent short rebuild and the string of target cuts were ahead of the data or simply catching up to it.
See the live data behind this article on ORTEX.
Open ALGT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
